DoctorDana-Farber Cancer InstituteBoston, Massachusetts, United States
I do not have any relevant financial / non-financial relationships with any proprietary interests.
25 - Immunogenicity and Reactogenicity of COVID-19 mRNA Vaccines in Allogeneic Stem Cell Transplant Recipients
On Demand
100 - Safety Analysis of Live-Attenuated Measles, Mumps, Rubella Vaccine Among Hematopoietic Cell Transplant Recipients Vaccinated Within Two Years of Transplant